Sign in to continue:

Tuesday, February 3rd, 2026

Trip.com-S (9961 HK) Positioned to Benefit from Rising Holiday Travel Demand

Date: 19 September 2024
Broker: MIB Securities (Hong Kong) Ltd


Increased Travel Demand

Trip.com-S (9961 HK) is poised to benefit from a surge in travel demand during China’s Mid-Autumn Festival holiday. According to the National Immigration Administration (NIA), a daily average of 1.8 million passenger trips is expected during the holiday period, marking a 21.9% increase from the previous year.

Boost from Upcoming Golden Week

Investor sentiment is expected to improve in anticipation of the National Day Golden Week, which runs from 1-7 October 2024. The Golden Week is historically one of the peak travel seasons for Chinese tourists, along with Lunar New Year and the Labour Day holiday. Strong travel demand during the Mid-Autumn Festival could set the stage for even greater demand during this key travel period, further benefiting Trip.com.

Strategic Opportunities

As a leading travel service provider, Trip.com is well-positioned to capture the increased travel demand during these important holiday seasons. The potential for higher travel volumes during both the Mid-Autumn Festival and Golden Week offers growth opportunities for Trip.com to strengthen its market position and revenue streams.


This summary encapsulates the key details regarding Trip.com-S (9961 HK) as presented in MIB Securities’ report dated 19 September 2024.

China Construction Bank-A (601939 CH) Stock Analysis 2025: Dividend Yield, Valuation, and Growth Outlook

Broker: OCBC Investment Research Date of Report: 27 June 2025 China Construction Bank and Peers: Why CCB Remains the Top Pick for Yield, Stability, and Growth Overview: Navigating China’s Banking Sector in 2025 In...

UMS Integration Ltd Bullish Continuation: Technical Analysis & Target Price Forecast for 2025

Broker Name: CGS International Date of Report: November 4, 2025 Excerpt from CGS International report. Report Summary UMS Integration Ltd shows a confirmed bullish continuation, supported by technical indicators such as a breakout from...

Is This the Next Big Thing in Pharma? Hansoh’s Growth Story You Can’t Ignore!

Hansoh Pharma (3692 HK) Investing in Hansoh Pharmaceutical Group Co. Ltd. (3692 HK) presents a compelling opportunity based on several key factors: 1. Robust Financial Performance: Hansoh Pharma has demonstrated strong revenue and earnings...